The Biotech Growth Trust PLC Stock

BIOG

GB0000385517

Investment Trusts

Market Closed - London S.E. Other stock markets 11:35:25 2026-02-16 am EST			5-day change	1st Jan Change
1,195.00 ^GBX	-1.65%		0.00%	-0.42%

Dec. 22	The Biotech Growth Trust Biomar Pharmaceuticals to acquire Biog portfolio company, Amicus Therapeutics	RE
Nov. 20	Biotech Growth Trust says while outlook is encouraging, challenges remain	RE

Valuation: The Biotech Growth Trust PLC

Capitalization	246M 336M 283M 259M 458M 30.5B 475M 3B 1.19B 14.68B 1.26B 1.23B 51.56B	P/E ratio 2024	4.81x	P/E ratio 2025	-2.87x
Enterprise value	238M 324M 274M 250M 442M 29.46B 459M 2.9B 1.15B 14.18B 1.22B 1.19B 49.8B	EV / Sales 2024	4.71x	EV / Sales 2025	-2.58x
Free-Float	99.56%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: The Biotech Growth Trust PLC

Timeframe

Style

Dynamic Chart

Latest news: The Biotech Growth Trust PLC

Dec. 22	The Biotech Growth Trust Biomar Pharmaceuticals to acquire Biog portfolio company, Amicus Therapeutics	RE
Nov. 20	Biotech Growth Trust says while outlook is encouraging, challenges remain	RE
Nov. 20	The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2025	CI
Nov. 14	The Biotech Growth Trust PLC commences an Equity Buyback Plan for 2,710,338 shares, representing 14.90% of its issued share capital, under the authorization approved on November 12, 2025.	CI
25-09-17	Biotech Growth Trust appoints former UKHSA head Jenny Harries to board	AN
25-08-20	Biotech Growth Trust says court confirms capital reduction	AN
25-06-05	Saturn Oil & Gas Inc.'s Board intends to launch an Equity Buyback.	CI
25-06-04	Biotech Growth Trust director buys GBP75,000 in shares	AN
25-06-04	Biotech Growth Trust underperforms benchmark as net asset value falls	AN
25-06-04	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-06-04	Tranche Update on The Biotech Growth Trust PLC's Equity Buyback Plan announced on July 19, 2024.	CI
25-02-27	The Biotech Growth Trust PLC's Equity Buyback announced on July 19, 2024 has expired.	CI
24-11-27	Biotech Growth Trust outperforms benchmark but notes currency drag	AN

More news

Press Releases: The Biotech Growth Trust PLC

Feb. 13	The Biotech Growth Trust PLC - Transaction in Own Shares	PR
Feb. 12	Biotech Growth Trust : January 2026 Factsheet	PU
Feb. 12	The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 January 2026	PR
Feb. 11	The Biotech Growth Trust PLC - Investor Presentation via Investor Meet Company	PR
Feb. 06	The Biotech Growth Trust PLC - Transaction in Own Shares	PR

More press releases

Managers and Directors: The Biotech Growth Trust PLC

Director	Title	Age	Since
Geoffrey Hsu BRD	Director/Board Member	-	2018-05-15
Nicola Shepherd BRD	Director/Board Member	-	2021-01-17
Roger Yates CHM	Chairman	68	-

More insiders

The Biotech Growth Trust PLC is a United Kingdom-based investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies. The Company invests approximately 10% in aggregate of the value of its gross assets in other closed-ended investment companies, including investment trusts listed on the London Stock Exchange. The Company invests approximately 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes Netherlands, the United States of America, Canada, and China. The Companyâ€™s alternative investment fund manager is Frostrow Capital LLP.

Employees

Sector

Investment Trusts

Calendar

May. 27 - Q4 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
26-02-16	1,195.00 p	-1.65%	9,684
26-02-13	1,215.00 p	+1.67%	38,079
26-02-12	1,195.00 p	+0.42%	72,241
26-02-11	1,190.00 p	-2.86%	44,514
26-02-10	1,225.00 p	+1.24%	46,948

Delayed Quote London S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.15

Average target price

Consensus

1 day	-1.65%
Current month	-0.83%
1 month	-6.27%
3 months	+3.91%
6 months	+40.92%
Current year	-0.42%

1 week	1,165	1,235
1 month	1,165	1,300
Current year	1,165	1,300
1 year	612.7	1,300
3 years	612.7	1,300
5 years	612.7	1,672.55
10 years	517.86	1,750

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
THE BIOTECH GROWTH TRUST PLC	-1.65%	0.00%	+40.26%	+25.79%	342M
Average	-1.65%	+1.67%	+40.26%	+25.79%	341.53M
Weighted average by Cap.	-1.65%	+1.67%	+40.26%	+25.79%

	2024	2025
Net sales	80.35M 110M 92.39M 84.28M 149M 9.94B 155M 979M 389M 4.79B 411M 402M 16.81B	-75.98M -104M -87.37M -79.7M -141M -9.4B -146M -926M -368M -4.53B -388M -380M -15.9B
Net income	74.6M 102M 85.78M 78.25M 139M 9.23B 144M 909M 361M 4.44B 381M 374M 15.61B	-82.66M -113M -95.05M -86.71M -154M -10.23B -159M -1.01B -400M -4.93B -423M -414M -17.29B
Net Debt	44.95M 61.27M 51.69M 47.15M 83.5M 5.56B 86.63M 548M 218M 2.68B 230M 225M 9.4B	-8.45M -11.52M -9.72M -8.87M -15.7M -1.05B -16.29M -103M -40.95M -504M -43.21M -42.32M -1.77B

The Biotech Growth Trust PLC Stock

Equities

BIOG

GB0000385517

Investment Trusts

Valuation: The Biotech Growth Trust PLC

Chart: The Biotech Growth Trust PLC

Latest news: The Biotech Growth Trust PLC

Press Releases: The Biotech Growth Trust PLC

Quotes and Performance

Course Extremes

Managers and Directors: The Biotech Growth Trust PLC

Investment Trusts

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus